Latest Breaking News On - Leap therapeutics - Page 1 : comparemela.com

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
Taiwan
Junshi
Anhui
China
Helsinki
Eteläuomen-läi
Finland
Germany
Qilu
Gansu

Leap Therapeutics Reports First Quarter 2024 Financial Results

Leap Therapeutics Reports First Quarter 2024 Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
United-states
Australia
American
Australian
Matthew-deyoung
Douglase-onsi
Prnewswire-leap-therapeutics-inc
American-society-of-clinical-oncology
Gilead-sciences-inc

LPTX Stock Earnings: Leap Therapeutics Beats EPS for Q1 2024

LPTX Stock Earnings: Leap Therapeutics Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Leap-therapeutics
Place-earnings

Leap Therapeutics (NASDAQ:LPTX) vs. Dyne Therapeutics (NASDAQ:DYN) Financial Survey

Leap Therapeutics (NASDAQ:LPTX – Get Free Report) and Dyne Therapeutics (NASDAQ:DYN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings. Volatility and Risk Leap Therapeutics has a beta […]

Australia
Japan
New-zealand
Waltham
Massachusetts
United-states
Cambridge
Cambridgeshire
United-kingdom
Beigene-ltd
Leap-therapeutics-inc

Financial Survey: Leap Therapeutics (NASDAQ:LPTX) & Dyne Therapeutics (NASDAQ:DYN)

Dyne Therapeutics (NASDAQ:DYN – Get Free Report) and Leap Therapeutics (NASDAQ:LPTX – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability. Institutional & Insider Ownership 96.7% of Dyne Therapeutics […]

Waltham
Massachusetts
United-states
Australia
New-zealand
Cambridge
Cambridgeshire
United-kingdom
Japan
Dyne-therapeutics-inc
Healthcare-pharmaceuticals-inc